Skip to main content
. 2021 Sep 20;49:116415. doi: 10.1016/j.bmc.2021.116415

Table 3.

Compounds arising from tripeptide modification and their predicted pocket occupancies.

Tripeptide for modification50 Potent compounds IC50 (µM)

Cap-Arg-Lys-Phg-NH2 Compound 3 IC50 = 0.21 µM
Compound 9 IC50 = 0.018 µM
Compound 12 IC50 = 0.46 ± 0.02 µM
Residues of inhibitor Predicted pocket occupancies

Compound 3* Compound 9# Compound 12

Phg/Phg modification# S1 S1 S1
Arg/Arg-mimetic* S2 S2 S2
Lys S1 S1, S3, S4 S1, S2
Cap group (varying) S3 S3, S4 S3, S4